Bucci Ann T
Quincy Retirement Community, PA, USA.
Geriatr Nurs. 2007 Mar-Apr;28(2):120-4; quiz 125. doi: 10.1016/j.gerinurse.2006.12.002.
In June 2005, the U.S. Centers for Medicare and Medicaid Services (CMS) issued revised guidance to surveyors for Section 483.25(d), Urinary Incontinence, Tag F315. Part 1 instructs that an indwelling catheter not be used without valid medical justification. Part 2 requires that a resident receive treatment to restore continence to the extent possible. Identification, assessment, and diagnosis of incontinence are crucial to preparing an individualized plan of care for treatment. Many articles discuss treatment protocols, but they do not focus on identification and assessment of the incontinent resident. The CHAMMP (Continence, History, Assessment, Medications, Mobility, Plan) Tool provides a comprehensive evaluation tool that incorporates information from the resident and provides the documentation necessary for the MDS (Minimum Data Set) and RAP (Resident Assessment Protocol) assessment process. It is used to establish an individualized plan of care.
2005年6月，美国医疗保险和医疗补助服务中心（CMS）向负责第483.25(d)条“尿失禁”（标签F315）的调查员发布了修订指南。第一部分指示，若无有效的医学理由，不得使用留置导尿管。第二部分要求尽可能为居民提供恢复控尿的治疗。失禁的识别、评估和诊断对于制定个性化的护理治疗计划至关重要。许多文章讨论了治疗方案，但它们没有关注失禁居民的识别和评估。CHAMMP（控尿、病史、评估、药物、活动能力、计划）工具提供了一个综合评估工具，该工具整合了居民的信息，并为MDS（最小数据集）和RAP（居民评估协议）评估过程提供了必要的文件。它用于制定个性化的护理计划。
